On Demand Webinar! Induction of receptor tyrosine kinase signaling by sera isolated from patients with lung adenocarcinoma
Speakers: Dr. Jeffrey A. Borgia, Department of Pathology, Department of Cell and Molecular Medicine, Rush University Medical Center; and Dr. Wen-Rong Lie, Principal Scientist, Merck
Watch WebinarFeatured Customer Story Interested in what MILLIPLEX® MAP kits can do for cancer research?
Read the SelectScience Article about Dr. Jeffery A. Borgia’s research: "Discover How Researchers at Rush Medical Center are Developing Novel Diagnostic Tests for Non-Small Cell Lung Cancer"
Read ArticleRead the White Paper on correlating angiogenesis biomarkers with early metastatic progression in NSCLC using our MILLIPLEX® map Human Angiogenesis/Growth Factor Magnetic Bead Panel 1 (Cat. No. HAGP1MAG-12K).
A tumor marker, or “biomarker,” is a molecular entity whose relative quantity or localization is different between tumor-bearing and non-tumor-bearing subjects. Cancer biomarker detection is important — not only for therapeutic use, but also because they can be used to decipher the signaling pathways underlying both normal and diseased cellular processes.
Accelerate Your Cancer Research using MILLIPLEX® MAP Multiplex Assays
Detection of isolated protein biomarkers is often inadequate to distinguish tumor from non-tumor. Multiplexed detection of both intracellular and circulating cancer markers can accelerate studies of normal homeostasis and tumorigenic processes, as long as your assays exhibit accuracy and lot-to-lot consistency.
Using the bead-based Luminex xMAP® platform, our MILLIPLEX® MAP cancer portfolio provides a broad offering of multiplexed cancer marker assays, compatible with serum, plasma, tissues, cultured cells, and other biological samples.
Our analytically validated kits and assays enable you to measure specific proteins in cancer research areas.